Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

FDA advisory committee will meet in January to review KeraVision Ring PMA

Dec. 9, 1998

Senju reports synthesis and evaluation of compounds with multiple pharmacological actions

Dec. 8, 1998

Photogen initiates development of ocular disease Rx; receives U.S. patents for technology

Dec. 7, 1998

Olopatadine combination more effective than loratadine monotherapy in allergic conjunctivitis

Nov. 27, 1998

CytoTherapeutics receives patent protection for ocular delivery of therapeutic substances

Nov. 25, 1998

First marketing approval granted for Vitrase in Mexico; U.S. phase III trials now under way

Nov. 24, 1998

Akorn announces U.S. market introduction for BioLon

Nov. 24, 1998

Latanoprost monotherapy is as effective as combination therapy in lowering IOP

Nov. 20, 1998

Three major studies support antiglaucoma efficacy of Cosopt

Nov. 19, 1998

Animal data suggest that GPI-1046 may be useful in glaucoma

Nov. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...